Proceptin 20 mg (Capsule (Enteric Coated))

Unit Price: ৳ 5.00 (10 x 10: ৳ 500.00)

Strip Price: ৳ 50.00

Medicine Details

Category	Details
Generic	Omeprazole
Company	Beximco pharmaceuticals ltd
Also available as	Proceptin 40 mg capsule Proceptin 40 mg injection

Gastric and duodenal ulcer
NSAID-associated duodenal and gastric ulcer
Prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
Gastro-esophageal reflux disease
Long-term management of acid reflux disease
Acid-related dyspepsia
Severe ulcerating reflux esophagitis
Prophylaxis of acid aspiration during general anesthesia
Zollinger-Ellison syndrome
Helicobacter pylori-induced peptic ulcer

20 mg once daily for benign gastric and duodenal ulcer (4-8 weeks duration)
20 mg once daily for NSAID-associated duodenal or gastric ulcer (4-8 weeks duration)
20 mg once daily for gastro-esophageal reflux disease (4-8 weeks duration; maintenance dose of 20 mg)
10-20 mg daily for long-term management of acid reflux disease
10-20 mg once daily for acid-related dyspepsia (2-4 weeks duration)
40 mg on the preceding evening, then 40 mg 2-6 hours before surgery for prophylaxis of acid aspiration
0-120 mg daily for Zollinger-Ellison syndrome (divided doses if daily dose >80 mg)
20 mg twice daily for Helicobacter pylori eradication regimen in peptic ulcer disease, in combination with antimicrobial agents
10-20 mg once daily for 4-12 weeks in severe ulcerating reflux esophagitis (paediatric use)

Omeprazole IV injection should be given as a slow intravenous injection
Omeprazole IV infusion should be given over a period of 20-30 minutes or more
Reconstituted solution should not be mixed or co-administered with any other drug in the same infusion set

Reduced absorption of ketoconazole
Delayed elimination of diazepam, phenytoin, and warfarin
Increased plasma concentrations of Proceptin and clarithromycin during concomitant administration
No evidence of interaction with phenacetin, theophylline, caffeine, propranolol, metoprolol, cyclosporin, lidocaine, quinidine, estradiol, amoxicillin, or antacids
No effect of alcohol or food on Omeprazole absorption
Increased bioavailability of digoxin during simultaneous treatment with Proceptin

Skin rash, urticaria, and pruritus
Photosensitivity, bullous eruption, erythema multiforme, angioedema, and alopecia
Diarrhoea, headache, constipation, nausea/vomiting, flatulence, and abdominal pain
Dry mouth, stomatitis, candidiasis, and paraesthesia
Dizziness, light-headedness, feeling faint, somnolence, insomnia, and vertigo
Reversible mental confusion, agitation, depression, and hallucinations
Arthritic and myalgic symptoms
Blurred vision, taste disturbance, peripheral oedema, increased sweating, gynaecomastia, leucopenia, thrombocytopenia, agranulocytosis, pancytopenia, anaphylactic shock, malaise, fever, bronchospasm, encephalopathy, hepatitis with or without jaundice, interstitial nephritis, hepatic failure, and increases in liver enzymes

No adverse effects on pregnancy and fetus/newborn child reported
Use during pregnancy is considered safe
No information available on passage of Omeprazole into breast milk or effects on the neonate
Breastfeeding should be discontinued if essential

Avoid concomitant use of clopidogrel and Proceptin
Possible association of PPI therapy with increased risk for osteoporosis-related fractures
Atrophic gastritis observed in patients treated long-term with Proceptin
Potential methotrexate toxicities with concomitant use of PPIs